Aspects on the integrative actions of the brain from neural networks to "brain-body medicine"

Journal of Receptors and Signal Transduction

Volumn 32, Issue 4, 2012, Pages 163-180

  Agnati, L F ^a   Guidolin, D ^b   Guescini, M ^c   Battistin, L ^a   Stocchi, V ^c   De Caro, R ^b   Genedani, S ^d   Fuxe, K ^e  

^a IRCCS SAN CAMILLO HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Brain integration; Intercellular communication; Microvesicles; Nucleus tractus solitarius; Receptor transfer; Tunneling nanotubes

Indexed keywords

ALPHA SYNUCLEIN; MICRORNA; MITOCHONDRIAL DNA; NANOTUBE; RNA;

BRAIN; BRAIN MAPPING; CELL COMMUNICATION; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; EXOSOME; INTEGRATIVE MEDICINE; NERVE CELL NETWORK; NERVE FIBER; NEUROTRANSMISSION; REVIEW; SYNAPSE;

ANIMALS; BRAIN; CELL COMMUNICATION; HUMANS; MIND-BODY THERAPIES; NERVE NET;

EID: 84864055258     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2012.687748     Document Type: Review

References (133)

1. Burke RE. Sir Charles Sherrington's the integrative action of the nervous system: A centenary appreciation. Brain 2007, 130, 887-894.
2. Gibson WC. (2002). Sir Charles Sherrington, O.M., P.R.S. (1857- 1952). In: Rose FC, ed. Twentieth century neurology. The British contribution. London: Imperial College Press, 1-7.
3. Levine DN. Sherrington's "The Integrative action of the nervous system": A centennial appraisal. J Neurol Sci 2007, 253, 1-6.
4. Breathnach CS. Charles Scott Sherrington's Integrative action: A centenary notice. J R Soc Med 2004, 97, 34-36.
5. Butt AM. ATP: A ubiquitous gliotransmitter integrating neuronglial networks. Semin Cell Dev Biol 2011, 22, 205-213.
6. Figley CR, Stroman PW. The role(s) of astrocytes and astrocyte activity in neurometabolism, neurovascular coupling, and the production of functional neuroimaging signals. Eur J Neurosci 2011, 33, 577-588.
7. Kettenmann H, Hanisch UK, Noda M, verkhratsky A. Physiology of microglia. Physiol Rev 2011, 91, 461-553.
8. Yi CX, Habegger KM, Chowen JA, Stern J, Tschop MH. A role for astrocytes in the central control of metabolism. Neuroendocrinology 2011, 93, 143-149.
9. Agnati LF, Fuxe K. volume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing's B-Type machine. Prog Brain Res 2000, 125, 3-19.
10. vizi ES, Kiss JP, Lendvai B. Nonsynaptic communication in the central nervous system. Neurochem Int 2004, 45, 443-451.
11. Agnati LF, Guidolin D, Guescini M, Genedani S, Fuxe K. Understanding wiring and volume transmission. Brain Res Rev 2010, 64, 137-159.
12. Jacob F. (1970). La logique du vivant. Une histoire de l'heredite. Paris: Gallimard Editions.
13. Agnati LF, Fuxe K. New concepts on the structure of the neuronal networks: The miniaturization and hierarchical organization of the central nervous system. (Hypothesis). Biosci Rep 1984, 4, 93-98.
14. Agnati LF, Guidolin D, Fuxe K. The brain as a system of nested but partially overlapping networks. Heuristic relevance of the model for brain physiology and pathology. J Neural Transm 2007, 114, 3-19.
15. Hebb DO. (1949). The organization of behavior. New York: John Wiley & Sons [Espanola, ed. Organizacion de la conducta. Madrid: Debate, (1985)].
16. Wang XJ. Synaptic reverberation underlying mnemonic persistent activity. Trends Neurosci 2001, 24, 455-463.
17. Agnati LF, Guidolin D, Carone C, Dam M, Genedani S, Fuxe K. Understanding neuronal molecular networks builds on neuronal cellular network architecture. Brain Res Rev 2008, 58, 379-399.
18. Anderson ML. Evolution of cognitive function via redeployment of brain areas. Neuroscientist 2007, 13, 13-21.
19. Anderson ML. Neural reuse: A fundamental organizational principle of the brain. Behav Brain Sci 2010, 33, 245-66; discussion 266.
20. Jacob F. Evolution and tinkering. Science 1977, 196, 1161-1166.
21. Eccles JC. (1964). The physiology of synapses. Berlin: Springer
22. Fuxe K. Cellular localization of monoamines in the median eminence and the infundibular stem of some mammals. Z Zellforsch Mikrosk Anat 1964, 61, 710-724.
23. Agnati LF, Fuxe K, Calza L, Goldstein M, Toffano G, Giardino L, Zoli M. Further studies on the effects of the GM1 ganglioside on the degenerative and regenerative features of mesostriatal dopamine neurons. Acta Physiol Scand Suppl 1984, 532, 37-44.
24. Kuhar MJ, Unnerstall JR, De Souza EB. Receptor mapping in neuropharmacology by autoradiography: Some technical problems. NIDA Res Monogr 1985, 62, 1-12.
25. Einarsson P, Hallman H, Jonsson G. Quantitative microfluorimetry of formaldehyde induced fluorescence of dopamine in the caudate nucleus. Med Biol 1975, 53, 15-24.
26. Sternberger LA. (1979). Immunocytochemistry. New York: John Wiley
27. Agnati LF, Andersson K, Wiesel F, Fuxe K. A method to determine dopamine levels and turnover rate in discrete dopamine nerve terminal systems by quantitative use of dopamine fluorescence obtained by Falck-Hillarp methodology. J Neurosci Methods 1979, 1, 365-373.
28. Agnati LF, Fuxe K, Benfenati F, Zini I, Zoli M, Fabri L, Harfstrand AI. Computer-Assisted morphometry and microdensitometry of transmitter-Identified neurons with special reference to the mesostriatal dopamine pathway: Methodological aspects. Acta Physiol Scand Suppl 1984, 532, 6-36.
29. Andersson K, Fuxe K, Agnati LF. Determinations of catecholamine half-Lives and turnover rates in discrete catecholamine nerve terminal systems of the hypothalamus, the preoptic region and the forebrain by quantitative histofluorimetry. Acta Physiol Scand 1985, 123, 411-426.
30. Jansson A, Goldstein M, Tinner B, Zoli M, Meador-Woodruff JH, Lew JY, Levey AI, Watson S, Agnati LF, Fuxe K. On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat. Neuroscience 1999, 89, 473-489.
31. Descarries L, Seguela P, Watkins KC. (1991). Nonjunctional relationship of monoamine axon terminals in the cerebral cortex of adult rat. In: Fuxe K, Agnati LF, eds. volume transmission in the brain: Novel mechanisms for neural transmission. New York: Raven Press, 53-62.
32. Agnati LF, Fuxe K, Zoli M, Ozini I, Toffano G, Ferraguti F. A correlation analysis of the regional distribution of central enkephalin and β-Endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: The volume transmission and the wiring transmission. Acta Physiol Scand 1986, 128, 201-207.
33. vizi ES. Non-Synaptic interactions between neurons: Modulation of neurochemical transmission. New York: John Wiley, 1984.
34. Nicholson C. Factors governing diffusing molecular signals in brain extracellular space. J Neural Transm 2005, 112, 29-44.
35. Agnati LF, Fuxe K, Nicholson C, Sykova E, eds. (2000). Progress in brain research: Volume transmission revisited. Amsterdam: Elsevier Science, 125.
36. Fuxe K, Dahlstrom AB, Jonsson G, Marcellino D, Guescini M, Dam M, Manger P, Agnati L. The discovery of central monoamine neurons gave volume transmission to the wired brain. Prog Neurobiol 2010, 90, 82-100.
37. Rodbell M. The complex regulation of receptor-Coupled G-Proteins. Adv Enzyme Regul 1997, 37, 427-435.
38. Gilman AG. Nobel Lecture. G proteins and regulation of adenylyl cyclase. Biosci Rep 1995, 15, 65-97.
39. Lefkowitz RJ. G protein-Coupled receptors. III. New roles for receptor kinases and β-Arrestins in receptor signaling and desensitization. J Biol Chem 1998, 273, 18677-18680.
40. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov 2006, 5, 993-996.
41. Agnati LF, Fuxe K, Zini I, Lenzi P, Hokfelt T. Aspects on receptor regulation and isoreceptor identification. Med Biol 1980, 58, 182-187.
42. Fuxe K, Agnati LF, Benfenati F, Celani M, Zini I, Zoli M, Mutt V. Evidence for the existence of receptor-Receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. J Neural Transm Suppl 1983, 18, 165-179.
43. Fuxe K, Canals M, Torvinen M, Marcellino D, Terasmaa A, Genedani S, Leo G, Guidolin D, Diaz-Cabiale Z, Rivera A, Lundstrom L, Langel U, Narvaez J, Tanganelli S, Lluis C, Ferre S, Woods A, Franco R, Agnati LF. Intramembrane receptor-Receptor interactions: A novel principle in molecular medicine. J Neural Transm 2007, 114, 49-75.
44. Agnati LF, Guidolin D, Leo G, Carone C, Genedani S, Fuxe K. Receptor-Receptor interactions: A novel concept in brain integration. Prog Neurobiol 2010, 90, 157-175.
45. Agnati LF, Fuxe K, Zoli M, Rondanini C, Ogren SO. New vistas on synaptic plasticity: The receptor mosaic hypothesis of the engram. Med Biol 1982, 60, 183-190.
46. Agnati LF, Barlow PW, Baluŝka F, Tonin P, Guescini M, Leo G, Fuxe K. A new theoretical approach to the functional meaning of sleep and dreaming in humans based on the maintenance of 'predictive psychic homeostasis'. Commun Integr Biol 2011, 4, 640-654.
47. Agnati LF, Guidolin D, Leo G, Fuxe K. A boolean network modelling of receptor mosaics relevance of topology and cooperativity. J Neural Transm 2007, 114, 77-92.
48. Kenakin T, Agnati LF, Caron M, Fredholm B, Guidoli D, Kobilka B, Lefkowitz RW, Lohse M, Woods A, Fuxe K. International Workshop at the Nobel Forum, Karolinska Institutet on G protein-Coupled receptors: Finding the words to describe monomers, oligomers, and their molecular mechanisms and defining their meaning. Can a consensus be reached? J Recept Signal Transduct Res 2010, 30, 284-286.
49. Agnati LF, Fuxe K. Subcortical limbic 3H-N-Propylnorapomorphine binding sites are markedly modulated by cholecystokinin-8 in vitro. Biosci Rep 1983, 3, 1101-1105.
50. Carlsson A, Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 1963, 20, 140-144.
51. Agnati LF, Franzen O, Ferre S, Leo G, Franco R, Fuxe K. Possible role of intramembrane receptor-Receptor interactions in memory and learning via formation of long-Lived heteromeric complexes: Focus on motor learning in the basal ganglia. J Neural Transm Suppl 2003, 65, 1-28.
52. Guidolin D, Fuxe K, Neri G, Nussdorfer GG, Agnati LF. On the role of receptor-Receptor interactions and volume transmission in learning and memory. Brain Res Rev 2007, 55, 119-133.
53. Schwarzschild MA, Agnati L, Fuxe K, Chen JF, Morelli M. Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci 2006, 29, 647-654.
54. Fuxe K, Marcellino D, Woods AS, Giuseppina L, Antonelli T, Ferraro L, Tanganelli S, Agnati LF. Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: Relevance for schizophrenia. J Neural Transm 2009, 116, 923-939.
55. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, Branski P, Ratajczak MZ, Zembala M. Tumourderived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 2006, 55, 808-818.
56. Rozmyslowicz T, Majka M, Kijowski J, Murphy SL, Conover DO, Poncz M, Ratajczak J, Gaulton GN, Ratajczak MZ. Platelet- and megakaryocyte-Derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIv. AIDS 2003, 17, 33-42.
57. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A. Rapid secretion of interleukin-1β by microvesicle shedding. Immunity 2001, 15, 825-835.
58. Rialland P, Lankar D, Raposo G, Bonnerot C, Hubert P. BCR-Bound antigen is targeted to exosomes in human follicular lymphoma B-Cells. Biol Cell 2006, 98, 491-501.
59. Hakelien AM, Landsverk HB, Robl JM, Skalhegg BS, Collas P. Reprogramming fibroblasts to express T-Cell functions using cell extracts. Nat Biotechnol 2002, 20, 460-466.
60. Pan BT, Teng K, Wu C, Adam M, Johnstone RM. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 1985, 101, 942-948.
61. Alais S, Simoes S, Baas D, Lehmann S, Raposo G, Darlix JL, Leblanc P. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol Cell 2008, 100, 603-615.
62. Al-Nedawi K, Meehan B, Micallef J, Lhotak v, May L, Guha A, Rak J. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008, 10, 619-624.
63. Alonso R, Rodriguez MC, Pindado J, Merino E, Merida I, Izquierdo M. Diacylglycerol kinase α regulates the secretion of lethal exosomes bearing fas ligand during activation-Induced cell death of T lymphocytes. J Biol Chem 2005, 280, 28439-28450.
64. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial expression of autocrine vEGF upon the uptake of tumor-Derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 2009, 106, 3794-3799.
65. Bakhti M, Winter C, Simons M. Inhibition of myelin membrane sheath formation by oligodendrocyte-Derived exosome-Like vesicles. J Biol Chem 2011, 286, 787-796.
66. Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, Cooper JM. Lysosomal dysfunction increases exosomemediated α-Synuclein release and transmission. Neurobiol Dis 2011, 42, 360-367.
67. Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2011, 2, 180.
68. Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, Gould SJ. Exosomes and HIv Gag bud from endosome-Like domains of the T cell plasma membrane. J Cell Biol 2006, 172, 923-935.
69. Castellana D, Zobairi F, Martinez MC, Panaro MA, Mitolo v, Freyssinet JM, Kunzelmann C. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: A role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res 2009, 69, 785-793.
70. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of β-Catenin: A novel mechanism that antagonizes Wnt signaling. J Cell Biol 2010, 190, 1079-1091.
71. Atay S, Gercel-Taylor C, Suttles J, Mor G, Taylor DD. Trophoblastderived exosomes mediate monocyte recruitment and differentiation. Am J Reprod Immunol 2011, 65, 65-77.
72. Chavez-Nunoz C, Kilani RT, Ghahary A. Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. J Cell Physiol 2009, 221, 221-231.
73. Aoki N, Jin-no S, Nakagawa Y, Asai N, Arakawa E, Tamura N, Tamura T, Matsuda T. Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: Redox- and hormone-Dependent induction of milk fat globule-Epidermal growth factor 8-Associated microvesicles. Endocrinology 2007, 148, 3850-3862.
74. Aoki N, Yokoyama R, Asai N, Ohki M, Ohki Y, Kusubata K, Heissig B, Hattori K, Nakagawa Y, Matsuda T. Adipocyte-Derived microvesicles are associated with multiple angiogenic factors and induce angiogenesis in vivo and in vitro. Endocrinology 2010, 151, 2567-2576.
75. Candela ME, Geraci F, Turturici G, Taverna S, Albanese I, Sconzo G. Membrane vesicles containing matrix metalloproteinase-9 and fibroblast growth factor-2 are released into the extracellular space from mouse mesoangioblast stem cells. J Cell Physiol 2010, 224, 144-151.
76. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, viltono L, Tetta C, Camussi G. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 2010, 5, e11803.
77. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G. Mesenchymal stem cell-Derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009, 20, 1053-1067.
78. Onfelt B, Nedvetzki S, Benninger RK, Purbhoo MA, Sowinski S, Hume AN, Seabra MC, Neil MA, French PM, Davis DM. Structurally distinct membrane nanotubes between human macrophages support long-Distance vesicular traffic or surfing of bacteria. J Immunol 2006, 177, 8476-8483.
79. Sowinski S, Jolly C, Berninghausen O, Purbhoo MA, Chauveau A, Kohler K, Oddos S, Eissmann P, Brodsky FM, Hopkins C, Onfelt B, Sattentau Q, Davis DM. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIv-1 transmission. Nat Cell Biol 2008, 10, 211-219.
80. Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH. Nanotubular highways for intercellular organelle transport. Science 2004, 303, 1007-1010.
81. Watkins SC, Salter RD. Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 2005, 23, 309-318.
82. Onfelt B, Nedvetzki S, Yanagi K, Davis DM. Cutting edge: Membrane nanotubes connect immune cells. J Immunol 2004, 173, 1511-1513.
83. Koyanagi M, Brandes RP, Haendeler J, Zeiher AM, Dimmeler S. Cell-To-Cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes: A novel mechanism for cell fate changes? Circ Res 2005, 96, 1039-1041.
84. Agnati LF, Guidolin D, Baluska F, Leo G, Barlow PW, Carone C, Genedani S. A new hypothesis of pathogenesis based on the divorce between mitochondria and their host cells: Possible relevance for Alzheimer's disease. Curr lzheimer Res 2010, 7, 307-322.
85. Domhan S, Ma L, Tai A, Anaya Z, Beheshti A, Zeier M, Hlatky L, Abdollahi A. Intercellular communication by exchange of cytoplasmic material via tunneling nano-Tube like structures in primary human renal epithelial cells. PLoS ONE 2011, 6, e21283.
86. Agnati LF, Guidolin D, Leo G, Guescini M, Pizzi M, Stocchi v, Spano PF, Ghidoni R, Ciruela F, Genedani S, Fuxe K. Possible new targets for GPCR modulation: Allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms. J Recept Signal Transduct Res 2011, 31, 315-331.
87. Fevrier B, Raposo G. Exosomes: Endosomal-Derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004, 16, 415-421.
88. Guescini M, Leo G, Genedani S, Carone C, Pederzoli F, Ciruela F, Guidolin D, Stocchi v, Mantuano M, Borroto-Escuela DO, Fuxe K, Agnati LF. Microvesicle and tunneling nanotube mediated intercellular transfer of G-Protein coupled receptors in cell cultures. Exp Cell Res 2012, 318, 603-613.
89. Shai E, varon D. Development, cell differentiation, angiogenesis- microparticles and their roles in angiogenesis. Arterioscler Thromb vasc Biol 2011, 31, 10-14.
90. Dunning CJ, Reyes JF, Steiner JA, Brundin P. Can Parkinson's disease pathology be propagated from one neuron to another? Prog Neurobiol 2011. doi:10.1016/j.pneurobio.2011.11.003
91. Hansen C, Angot E, Bergstrom AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R, Kallunki P, Fog K, Li JY, Brundin P. a-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 2011, 121, 715-725.
92. Brundin P, Barker RA, Parmar M. Neural grafting in Parkinson's disease Problems and possibilities. Prog Brain Res 2010, 184, 265-294.
93. Angot E, Steiner JA, Hansen C, Li JY, Brundin P. Are synucleinopathies prion-Like disorders? Lancet Neurol 2010, 9, 1128-1138.
94. Kordower JH, Brundin P. Propagation of host disease to grafted neurons: Accumulating evidence. Exp Neurol 2009, 220, 224-225.
95. Brundin P, Melki R, Kopito R. Prion-Like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 2010, 11, 301-307.
96. Steiner JA, Angot E, Brundin P. A deadly spread: Cellular mechanisms of a-Synuclein transfer. Cell Death Differ 2011, 18, 1425-1433.
97. Angot E, Brundin P. Dissecting the potential molecular mechanisms underlying á-Synuclein cell-To-Cell transfer in Parkinson's disease. Parkinsonism Relat Disord 2009, 15 Suppl 3, S143-S147.
98. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez- Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005, 113, 752-760.
99. Deregibus MC, Cantaluppi v, Calogero R, Lo Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B, Camussi G. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007, 110, 2440-2448.
100. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena- Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10, 1470-1476.
101. Guescini M, Genedani S, Stocchi v, Agnati LF. Astrocytes and glioblastoma cells release exosomes carrying mtDNA. J Neural Transm 2010, 117, 1-4.
102. Guescini M, Guidolin D, vallorani L, Casadei L, Gioacchini AM, Tibollo P, Battistelli M, Falcieri E, Battistin L, Agnati LF, Stocchi V. C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Exp Cell Res 2010, 316, 1977-1984.
103. Alvarez vA, Sabatini BL. Anatomical and physiological plasticity of dendritic spines. Annu Rev Neurosci 2007, 30, 79-97.
104. Getting PA, Denkin MS. (1985). Tritonia swimming: A model system for integration within rhythmic motor systems. In: Selverston AI, ed. Model neural networks and behaviour. New York: Plenum Press
105. Cameron OG. visceral brain-Body information transfer. Neuroimage 2009, 47, 787-794.
106. Craig AD. How do you feel-now? The anterior insula and humanawareness. Nat RevNeurosci 2009, 10, 59-70.
107. Damasio AR, ed. (1993). Descartes' error: Emotion, reason, and the human brain. New York: Putnam.
108. Critchley HD, Wiens S, Rotshtein P, Ohman A, Dolan RJ. Neural systems supporting interoceptive awareness. Nat Neurosci 2004, 7, 189-195.
109. Levine DS. Brain pathways for cognitive-Emotional decision making in the human animal. Neural Netw 2009, 22, 286-293.
110. Hagemann D, Waldstein SR, Thayer JF. Central and autonomic nervous system integration in emotion. Brain Cogn 2003, 52, 79-87.
111. Pessoa L. Emergent processes in cognitive-Emotional interactions. Dialogues Clin Neurosci 2010, 12, 433-448.
112. Salzman CD, Fusi S. Emotion, cognition, and mental state representation in amygdala and prefrontal cortex. Annu Rev Neurosci 2010, 33, 173-202.
113. Aradachi H, Honda K, Negoro H, Kubota T. Median preoptic neurones projecting to the supraoptic nucleus are sensitive to haemodynamic changes as well as to rise in plasma osmolality in rats. J Neuroendocrinol 1996, 8, 35-43.
114. Levin BE, Kang L, Sanders NM, Dunn-Neynell AA. Role of neuronal glucosensing in the regulation of energy homeostasis. Diabetes 2006, 55, S122-S130.
115. Dean JB, Putnam RW. The caudal solitary complex is a site of central CO(2) chemoreception and integration of multiple systems that regulate expired CO(2). Respir Physiol Neurobiol 2010, 173, 274-287.
116. Melnick Iv, Price CJ, Colmers WF. Glucosensing in parvocellular neurons of the rat hypothalamic paraventricular nucleus. Eur J Neurosci 2011, 34, 272-282.
117. valassi E, Scacchi M, Cavagnini F. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 2008, 18, 158-168.
118. Hoyda TD, Samson WK, Ferguson Av. Adiponectin depolarizes parvocellular paraventricular nucleus neurons controlling neuroendocrine and autonomic function. Endocrinology 2009, 150, 832-840.
119. Hayes MR, De Jonghe BC, Kanoski SE. Role of the glucagon-Likepeptide- 1 receptor in the control of energy balance. Physiol Behav 2010, 100, 503-510.
120. Marino JS, Xu Y, Hill JW. Central insulin and leptin-Nediated autonomic control of glucose homeostasis. Trends Endocrinol Metab 2011, 22, 275-285.
121. Lane RD, Wager TD. Introduction to a special issue of Neuroimage on brain-Body medicine. Neuroimage 2009, 47, 781-784.
122. Lane RD, Wager TD. The new field of Brain-Body Medicine: What have we learned and where are we headed? Neuroimage 2009, 47, 1135-1140.
123. Damasio A, Meyer K. Behind the looking-Glass. Nature 2008, 454, 167-168.
124. Golgi C. (1914). La moderna evoluzione delle dottrine delle conoscenze sulla vita. Milano: Rendiconti Regio Istituto Lombardo, XLvII (1).
125. Coltheart M. (2001). Assumptions and methods in cognitive neuropsychology. In: Rapp B, ed. The handbook of cognitive neuropsychology. New York: Psychology Press, 3-21.
126. Anderson ML, Pessoa L. (2011). Quantifying the diversity of neural activations in individual brain regions. In: Carlson L, Holscher C, Shipley T, eds. Proceedings of the 33rd Annual Conference of Cognitive Society. Austin: Cognitive Science Society, 2421-2426.
127. Taylor J, ed. (1932). Selected Writings of John Hughlings Jackson. London: Hodder & Stoughton, 2.
128. Capaday C. The integrated nature of motor cortical function. Neuroscientist 2004, 10, 207-220.
129. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J, Zhang L, Steinman L, Miller D, Zhang HG. Treatment of brain inflammatory diseases by delivering exosome encapsulated antiinflammatory drugs from the nasal region to the brain. Mol Ther 2011, 19, 1769-1779.
130. Thayer JF, Brosschot JF. Psychosomatics and psychopathology: Looking up and down from the brain. Psychoneuroendocrinology 2005, 30, 1050-1058.
131. Lane RD, McRae K, Reiman EM, Chen K, Ahern GL, Thayer JF. Neural correlates of heart rate variability during emotion. Neuroimage 2009, 44, 213-222.
132. Zoli M, Zini I, Agnati LF, Guidolin D, Ferraguti F, Fuxe K. Aspects of neural plasticity in the central nervous system-I. Computerassisted image analysis methods. Neurochem Int 1990, 16, 383-418.
133. Guidolin D, Albertin G, Guescini M, Fuxe K, Agnati LF. Central nervous system and computation. Q Rev Biol 2011, 86, 265-285.